Search results for "molecular microbiology"

Sebastian Peck discusses an automated high-content imaging solution designed to deliver more precise results from complex biological assays

Fujifilm Wako Chemicals Europe is accelerating drug discovery and development by providing a range of services encompassing rabbit monoclonal antibody discovery, AI-driven drug discovery, neural cell assay services, cyclic peptide discovery, and more

Candida auris (C.auris) infections are a major global health challenge, with nosocomial outbreaks on the rise and many strains exhibiting resistance to antifungal agents. New real-time PCR tests enable sensitive and specific identification of the pathogen and of the most important mutations associated with resistance to echinocandins (ECH).

A versatile Stomacher® designed for the BAM testing procedure as well as large volume blending and extraction.

The Company will also be providing an update to its distributors and other customers on July 26 at 11 am CT

The Dianthus instrument includes breakthrough Spectral Shift technology for affinity-based screenings in drug discovery

How customer feedback shaped the NuWind multi-application centrifuge

Advancements to include CosMx® Whole Transcriptome Panel; enhanced technology engine to power CellScape™ for spatial proteomics; expansion to 1000-plex protein assay on GeoMx® DSP; and launch of PaintScape™, a revolutionary platform enabling direct visualization of the 3D genome

Learn how a US company is changing the paradigm for contract research, combining disease pharmacology, toxicology, and pathology to optimize drug development

Leveraging duplex NGS with automated library prep, researchers move closer to developing liquid biopsy tests for rare genetic disorders

Industry experts discuss the role of artificial intelligence in the fight against COVID-19, the lessons learned and its future promise in healthcare

How CLINICAL24 ambassador, Susan Dawson, drives innovation and efficiency through thoughtful clinical laboratory management amidst staffing and budget challenges

One test that can expedite NSCLC treatment selection decisions. The Oncomine Dx Target Test is the first targeted NGS-based in vitro diagnostic test for NSCLC, simultaneously delivering multiple biomarker results from one sample within four days and helping inform treatment decisions.

The "Pearl Effect" - Maximum recovery and reproducibility with epT.I.P.S. LoRetention and ep Dualfilter T.I.P.S. LoRetention - No sample loss, reduced costs, improved results

Versatile electroporation system suitable for applications for gene, drug and protein delivery including: mammalian cells, in vivo, ex vivo, in ovo tissue, ex plant, nuclear transfer and CRISPR NEW! Now available with Pulse Switcher for automatic polarity switching!

For simultaneous whole genome sequencing and whole transcriptome sequencing library preparation from a single sample